Tag:
NCX 116
Latest Headlines
Latest Headlines
NicOx gains new partner on glaucoma program
France's NicOx is pocketing a $10 million upfront from Bausch & Lomb to develop and market its glaucoma eye therapy NCX 116. And it stands to earn another $169.5 million in milestones in the
